Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041545 · ClinicalTrials.gov registry record
Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 32
- Enrollment target
NCT03041545: Completed study, sponsored by University of California, San Diego.
NCT03041545 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03041545 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Physical activity during chemotherapy has been shown to increase patient health and wellbeing as well as improve outcomes in breast cancer patients. The primary aim of this project is to determine the feasibility of incorporating wearable sensors into clinical care by having breast cancer patients, undergoing chemotherapy, wear a commercially available monitor (Fitbit) that tracks physical activity, sleep, and heart rate monitor.
Primary Outcome
Enrolling \>20% of eligible patients
Interventions
- DEVICE Fitbit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2018-02-08 |
What the finished NCT03041545 record still lists
NCT03041545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fitbit is the first listed.
NCT03041545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03041545 about?
NCT03041545 is a clinical study titled "Tracking Physical Activity Throughout Chemotherapy for Breast Cancer". Physical activity during chemotherapy has been shown to increase patient health and wellbeing as well as improve outcomes in breast cancer patients. The primary aim of this project is to determine the feasibility of incorporating wearable sensors into clinical care by having breast cancer patients, ...
What is the current status of trial NCT03041545?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-06-01. Estimated completion is 2018-02-08.
What interventions are being tested in trial NCT03041545?
The interventions under investigation include: Fitbit (DEVICE).
Who is sponsoring clinical trial NCT03041545?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI